0001209191-21-009039.txt : 20210209
0001209191-21-009039.hdr.sgml : 20210209
20210209195026
ACCESSION NUMBER: 0001209191-21-009039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamond David
CENTRAL INDEX KEY: 0001770790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39976
FILM NUMBER: 21608638
MAIL ADDRESS:
STREET 1: C/O CORTEXYME, INC.
STREET 2: 269 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucira Health, Inc.
CENTRAL INDEX KEY: 0001652724
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 272491037
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (814) 574-1546
MAIL ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: DiAssess Inc.
DATE OF NAME CHANGE: 20150908
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-09
0
0001652724
Lucira Health, Inc.
LHDX
0001770790
Lamond David
1412 62ND STREET
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2021-02-09
4
C
0
53629
A
53629
I
See footnote
Common Stock
2021-02-09
4
C
0
92756
A
146385
I
See footnote
Common Stock
125281
D
Series B Preferred Stock
2021-02-09
4
C
0
53629
0.00
D
02/09/2021
53629
0
I
See footnote
Series C Preferred Stock
2021-02-09
4
C
0
92756
0.00
D
02/09/2021
92756
0
I
See footnote
Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.
The shares are held by Blue Devil Trust, for which Mr. Lamond serves as a trustee.
/s/ Dan George, Attorney-in-Fact for David Lamond
2021-02-09